Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach

Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of thoracic and cardiovascular surgery 2009-12, Vol.138 (6), p.1339-1348
Hauptverfasser: Montant, Patrick, MD, Chenot, Fabien, MD, Robert, Annie, PhD, Vancraeynest, David, MD, Pasquet, Agnès, MD, PhD, Gerber, Bernard, MD, PhD, Noirhomme, Philippe, MD, El Khoury, Gébrine, MD, Vanoverschelde, Jean-Louis, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1348
container_issue 6
container_start_page 1339
container_title The Journal of thoracic and cardiovascular surgery
container_volume 138
creator Montant, Patrick, MD
Chenot, Fabien, MD
Robert, Annie, PhD
Vancraeynest, David, MD
Pasquet, Agnès, MD, PhD
Gerber, Bernard, MD, PhD
Noirhomme, Philippe, MD
El Khoury, Gébrine, MD
Vanoverschelde, Jean-Louis, MD, PhD
description Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.
doi_str_mv 10.1016/j.jtcvs.2009.03.046
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734154953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022522309005017</els_id><sourcerecordid>734154953</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</originalsourceid><addsrcrecordid>eNqFks-q1DAUxoso3uvVJxAkG9HNjCdJ02kFhcvFfzDgQgV3IZOedjK2ac3JdJid7-BT-Ro-iakzKLhxk0Dy-77vkC9Z9pDDkgMvnu2Wu2gnWgqAaglyCXlxK7vkUK0WRak-384uAYRYKCHkRXaPaAcAK-DV3eyCV0UBslSX2Y_14NtFxNAz2ofJTaZjzjNDx36MQ2-is2xMK_pI7ODilhFOGJDV2KLHkK4mZL2LIQkDtvvQupgOB_-cXbMxDCN6cvHIyA4Bf377vjGENbNDP5rgaPBsg_GAmCI9QxO64zxH62yyo2QasT2mq5qZpPGEYTolxoAm9mkqZsaUYuz2fnanMR3hg_N-lX16_erjzdvF-v2bdzfX64VVgsdFVcKmAFWsSiuqvARRbyrFsWhKKQvLbW5NrhSXjVSgRGOUVcoKoZr5eLMy8ip7cvJNsV_3SFH3jix2nfE47EmvZM5VXimZSHkibRiIAjZ6DK434ag56LlCvdO_K9RzhRqkThUm1aOz_37TY_1Xc-4sAY_PgKH0TE0w3jr6wwnBy7ysysQ9PXFb124PLqCm3nRdsuVzLHFZ6kJzKauEvjihmB5uchg02VS5xTrJbNT14P4z88t_9LZzfi7xCx6RdsM--NSJ5pqEBv1h_pjzv4QKQAFfyV8y0eTP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734154953</pqid></control><display><type>article</type><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</creator><creatorcontrib>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><description>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank &lt; 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</description><identifier>ISSN: 0022-5223</identifier><identifier>EISSN: 1097-685X</identifier><identifier>DOI: 10.1016/j.jtcvs.2009.03.046</identifier><identifier>PMID: 19660385</identifier><identifier>CODEN: JTCSAQ</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Atrial Fibrillation - complications ; Biological and medical sciences ; Cardiology. Vascular system ; Cardiothoracic Surgery ; Echocardiography ; Endocardial and cardiac valvular diseases ; Female ; Heart ; Humans ; Hypertension, Pulmonary - complications ; Male ; Medical sciences ; Middle Aged ; Mitral Valve Insufficiency - complications ; Mitral Valve Insufficiency - mortality ; Mitral Valve Insufficiency - surgery ; Mitral Valve Insufficiency - therapy ; Pneumology ; Propensity Score ; Proportional Hazards Models ; Treatment Outcome</subject><ispartof>The Journal of thoracic and cardiovascular surgery, 2009-12, Vol.138 (6), p.1339-1348</ispartof><rights>The American Association for Thoracic Surgery</rights><rights>2009 The American Association for Thoracic Surgery</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</citedby><cites>FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022522309005017$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22184898$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19660385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montant, Patrick, MD</creatorcontrib><creatorcontrib>Chenot, Fabien, MD</creatorcontrib><creatorcontrib>Robert, Annie, PhD</creatorcontrib><creatorcontrib>Vancraeynest, David, MD</creatorcontrib><creatorcontrib>Pasquet, Agnès, MD, PhD</creatorcontrib><creatorcontrib>Gerber, Bernard, MD, PhD</creatorcontrib><creatorcontrib>Noirhomme, Philippe, MD</creatorcontrib><creatorcontrib>El Khoury, Gébrine, MD</creatorcontrib><creatorcontrib>Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><title>The Journal of thoracic and cardiovascular surgery</title><addtitle>J Thorac Cardiovasc Surg</addtitle><description>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank &lt; 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Atrial Fibrillation - complications</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Cardiothoracic Surgery</subject><subject>Echocardiography</subject><subject>Endocardial and cardiac valvular diseases</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - complications</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mitral Valve Insufficiency - complications</subject><subject>Mitral Valve Insufficiency - mortality</subject><subject>Mitral Valve Insufficiency - surgery</subject><subject>Mitral Valve Insufficiency - therapy</subject><subject>Pneumology</subject><subject>Propensity Score</subject><subject>Proportional Hazards Models</subject><subject>Treatment Outcome</subject><issn>0022-5223</issn><issn>1097-685X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks-q1DAUxoso3uvVJxAkG9HNjCdJ02kFhcvFfzDgQgV3IZOedjK2ac3JdJid7-BT-Ro-iakzKLhxk0Dy-77vkC9Z9pDDkgMvnu2Wu2gnWgqAaglyCXlxK7vkUK0WRak-384uAYRYKCHkRXaPaAcAK-DV3eyCV0UBslSX2Y_14NtFxNAz2ofJTaZjzjNDx36MQ2-is2xMK_pI7ODilhFOGJDV2KLHkK4mZL2LIQkDtvvQupgOB_-cXbMxDCN6cvHIyA4Bf377vjGENbNDP5rgaPBsg_GAmCI9QxO64zxH62yyo2QasT2mq5qZpPGEYTolxoAm9mkqZsaUYuz2fnanMR3hg_N-lX16_erjzdvF-v2bdzfX64VVgsdFVcKmAFWsSiuqvARRbyrFsWhKKQvLbW5NrhSXjVSgRGOUVcoKoZr5eLMy8ip7cvJNsV_3SFH3jix2nfE47EmvZM5VXimZSHkibRiIAjZ6DK434ag56LlCvdO_K9RzhRqkThUm1aOz_37TY_1Xc-4sAY_PgKH0TE0w3jr6wwnBy7ysysQ9PXFb124PLqCm3nRdsuVzLHFZ6kJzKauEvjihmB5uchg02VS5xTrJbNT14P4z88t_9LZzfi7xCx6RdsM--NSJ5pqEBv1h_pjzv4QKQAFfyV8y0eTP</recordid><startdate>20091201</startdate><enddate>20091201</enddate><creator>Montant, Patrick, MD</creator><creator>Chenot, Fabien, MD</creator><creator>Robert, Annie, PhD</creator><creator>Vancraeynest, David, MD</creator><creator>Pasquet, Agnès, MD, PhD</creator><creator>Gerber, Bernard, MD, PhD</creator><creator>Noirhomme, Philippe, MD</creator><creator>El Khoury, Gébrine, MD</creator><creator>Vanoverschelde, Jean-Louis, MD, PhD</creator><general>Mosby, Inc</general><general>AATS/WTSA</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091201</creationdate><title>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</title><author>Montant, Patrick, MD ; Chenot, Fabien, MD ; Robert, Annie, PhD ; Vancraeynest, David, MD ; Pasquet, Agnès, MD, PhD ; Gerber, Bernard, MD, PhD ; Noirhomme, Philippe, MD ; El Khoury, Gébrine, MD ; Vanoverschelde, Jean-Louis, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-980b605678c294802db951e6f8336c1c4ca45513f35052fa5c55c225fa455b7a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Atrial Fibrillation - complications</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Cardiothoracic Surgery</topic><topic>Echocardiography</topic><topic>Endocardial and cardiac valvular diseases</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - complications</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mitral Valve Insufficiency - complications</topic><topic>Mitral Valve Insufficiency - mortality</topic><topic>Mitral Valve Insufficiency - surgery</topic><topic>Mitral Valve Insufficiency - therapy</topic><topic>Pneumology</topic><topic>Propensity Score</topic><topic>Proportional Hazards Models</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montant, Patrick, MD</creatorcontrib><creatorcontrib>Chenot, Fabien, MD</creatorcontrib><creatorcontrib>Robert, Annie, PhD</creatorcontrib><creatorcontrib>Vancraeynest, David, MD</creatorcontrib><creatorcontrib>Pasquet, Agnès, MD, PhD</creatorcontrib><creatorcontrib>Gerber, Bernard, MD, PhD</creatorcontrib><creatorcontrib>Noirhomme, Philippe, MD</creatorcontrib><creatorcontrib>El Khoury, Gébrine, MD</creatorcontrib><creatorcontrib>Vanoverschelde, Jean-Louis, MD, PhD</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montant, Patrick, MD</au><au>Chenot, Fabien, MD</au><au>Robert, Annie, PhD</au><au>Vancraeynest, David, MD</au><au>Pasquet, Agnès, MD, PhD</au><au>Gerber, Bernard, MD, PhD</au><au>Noirhomme, Philippe, MD</au><au>El Khoury, Gébrine, MD</au><au>Vanoverschelde, Jean-Louis, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach</atitle><jtitle>The Journal of thoracic and cardiovascular surgery</jtitle><addtitle>J Thorac Cardiovasc Surg</addtitle><date>2009-12-01</date><risdate>2009</risdate><volume>138</volume><issue>6</issue><spage>1339</spage><epage>1348</epage><pages>1339-1348</pages><issn>0022-5223</issn><eissn>1097-685X</eissn><coden>JTCSAQ</coden><abstract>Aims The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair. Methods One hundred ninety-two asymptomatic patients (mean age, 63 ± 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years. Results Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a “conservative approach” group (n = 67) and an “early surgery” group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% ± 7% vs 86% ± 4%, log-rank &lt; 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively. Conclusion Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>19660385</pmid><doi>10.1016/j.jtcvs.2009.03.046</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-5223
ispartof The Journal of thoracic and cardiovascular surgery, 2009-12, Vol.138 (6), p.1339-1348
issn 0022-5223
1097-685X
language eng
recordid cdi_proquest_miscellaneous_734154953
source MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Atrial Fibrillation - complications
Biological and medical sciences
Cardiology. Vascular system
Cardiothoracic Surgery
Echocardiography
Endocardial and cardiac valvular diseases
Female
Heart
Humans
Hypertension, Pulmonary - complications
Male
Medical sciences
Middle Aged
Mitral Valve Insufficiency - complications
Mitral Valve Insufficiency - mortality
Mitral Valve Insufficiency - surgery
Mitral Valve Insufficiency - therapy
Pneumology
Propensity Score
Proportional Hazards Models
Treatment Outcome
title Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: A propensity score–based comparison between an early surgical strategy and a conservative treatment approach
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20survival%20in%20asymptomatic%20patients%20with%20severe%20degenerative%20mitral%20regurgitation:%20A%20propensity%20score%E2%80%93based%20comparison%20between%20an%20early%20surgical%20strategy%20and%20a%20conservative%20treatment%20approach&rft.jtitle=The%20Journal%20of%20thoracic%20and%20cardiovascular%20surgery&rft.au=Montant,%20Patrick,%20MD&rft.date=2009-12-01&rft.volume=138&rft.issue=6&rft.spage=1339&rft.epage=1348&rft.pages=1339-1348&rft.issn=0022-5223&rft.eissn=1097-685X&rft.coden=JTCSAQ&rft_id=info:doi/10.1016/j.jtcvs.2009.03.046&rft_dat=%3Cproquest_cross%3E734154953%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=734154953&rft_id=info:pmid/19660385&rft_els_id=1_s2_0_S0022522309005017&rfr_iscdi=true